Advanced

A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.

Johnsson, Anders LU ; Hagman, Helga LU ; Frödin, Jan-Erik; Berglund, Åke; Keldsen, N.; Fernebro, Eva LU ; Sundberg, J; De Pont Christensen, R; Garm Spindler, K-L and Bergström, D, et al. (2013) In Annals of Oncology 24(9). p.2335-2341
Abstract
The main objective was to study the effect on progression-free survival (PFS) of adding erlotinib to bevacizumab as maintenance treatment following chemotherapy and bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC).
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Annals of Oncology
volume
24
issue
9
pages
2335 - 2341
publisher
Oxford University Press
external identifiers
  • wos:000323963100020
  • pmid:23788755
  • scopus:84883339111
ISSN
1569-8041
DOI
10.1093/annonc/mdt236
language
English
LU publication?
no
id
cbc307cd-b479-4a04-bb4d-7eb9196c2887 (old id 3913091)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/23788755?dopt=Abstract
date added to LUP
2013-07-01 15:09:21
date last changed
2019-04-23 01:16:58
@article{cbc307cd-b479-4a04-bb4d-7eb9196c2887,
  abstract     = {The main objective was to study the effect on progression-free survival (PFS) of adding erlotinib to bevacizumab as maintenance treatment following chemotherapy and bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC).},
  author       = {Johnsson, Anders and Hagman, Helga and Frödin, Jan-Erik and Berglund, Åke and Keldsen, N. and Fernebro, Eva and Sundberg, J and De Pont Christensen, R and Garm Spindler, K-L and Bergström, D and Jakobsen, A},
  issn         = {1569-8041},
  language     = {eng},
  number       = {9},
  pages        = {2335--2341},
  publisher    = {Oxford University Press},
  series       = {Annals of Oncology},
  title        = {A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.},
  url          = {http://dx.doi.org/10.1093/annonc/mdt236},
  volume       = {24},
  year         = {2013},
}